Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 101201-101250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04483089
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device (bRIGHT)
N/A
Active, not recruiting
511 participants
Started: Aug 27, 2020 · Completed: Jan 31, 2028
1 condition
1 sponsor
26 locations
NCT04210492
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
PHASE1/PHASE2
Recruiting
36 participants
Started: Aug 26, 2020 · Completed: Jan 31, 2030
1 condition
1 sponsor
6 locations
NCT03688178
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PHASE2
Active, not recruiting
43 participants
Started: Aug 26, 2020 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05697939
3D Body Surface Modeling for Scoliosis Monitoring
N/A
Recruiting
13 participants
Started: Aug 26, 2020 · Completed: Jan 1, 2030
1 condition
1 sponsor
1 location
NCT04233866
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
PHASE2
Active, not recruiting
176 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2026
2 conditions
2 sponsors
760 locations
NCT04263597
Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
PHASE1/PHASE2
Active, not recruiting
70 participants
Started: Aug 26, 2020 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT04224064
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
NA
Recruiting
158 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT04460248
Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
Active, not recruiting
40 participants
Started: Aug 26, 2020 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT04915027
Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care
NA
Recruiting
1,106 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2027
1 condition
17 sponsors
1 location
NCT06524427
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NA
Recruiting
1,124 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2030
1 condition
24 sponsors
24 locations
NCT04243720
Immune Resistance Interrogation Study
N/A
Recruiting
100 participants
Started: Aug 26, 2020 · Completed: Feb 28, 2025
4 conditions
1 sponsor
1 location
NCT04537013
Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee
NA
Active, not recruiting
234 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2028
4 conditions
1 sponsor
15 locations
NCT04317482
The Human Stress Response in a Simulated ED Setting
NA
Active, not recruiting
30 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT04572321
Youth Depression and Suicide Research Network
N/A
Enrolling by invitation
5,000 participants
Started: Aug 26, 2020 · Completed: Sep 30, 2032
10 conditions
1 sponsor
1 location
NCT04323189
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
PHASE4
Active, not recruiting
20 participants
Started: Aug 26, 2020 · Completed: Feb 28, 2026
3 conditions
1 sponsor
1 location
NCT04065009
The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer
PHASE3
Active, not recruiting
220 participants
Started: Aug 26, 2020 · Completed: Aug 26, 2028
1 condition
2 sponsors
1 location
NCT04850053
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
N/A
Recruiting
1,500 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2024
1 condition
11 sponsors
1 location
NCT04109729
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
PHASE1
Active, not recruiting
39 participants
Started: Aug 25, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05911100
State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19
N/A
Active, not recruiting
100 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05822427
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
N/A
Recruiting
75 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2039
1 condition
1 sponsor
1 location
NCT04452162
Physiologic MR Imaging of Salivary Gland Tumors
NA
Recruiting
30 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04614480
Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine
PHASE2
Recruiting
7,976 participants
Started: Aug 25, 2020 · Completed: Sep 2, 2032
1 condition
1 sponsor
12 locations
NCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
NA
Recruiting
545 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2028
1 condition
1 sponsor
22 locations
NCT04523272
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
PHASE3
Active, not recruiting
528 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
39 locations
NCT04505254
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
PHASE2
Recruiting
60 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT04444492
Combination of Ranibizumab and Targeted Laser Photocoagulation
PHASE3
Recruiting
110 participants
Started: Aug 25, 2020 · Completed: Nov 30, 2027
1 condition
2 sponsors
15 locations
NCT04504825
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
PHASE3
Active, not recruiting
125 participants
Started: Aug 25, 2020 · Completed: Oct 22, 2027
1 condition
1 sponsor
90 locations
NCT04185974
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
NA
Recruiting
72 participants
Started: Aug 25, 2020 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT04236908
Accessible Acupuncture for the Warrior With Acute Low Back Pain
NA
Active, not recruiting
276 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04239157
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
PHASE2
Recruiting
76 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2026
6 conditions
3 sponsors
1 location
NCT03898596
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
NA
Recruiting
150 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04285086
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
PHASE3
Active, not recruiting
174 participants
Started: Aug 25, 2020 · Completed: Aug 31, 2029
1 condition
1 sponsor
65 locations
NCT04514653
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)
PHASE2
Recruiting
115 participants
Started: Aug 25, 2020 · Completed: Aug 1, 2026
1 condition
1 sponsor
15 locations
NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
PHASE3
Active, not recruiting
615 participants
Started: Aug 25, 2020 · Completed: Aug 26, 2028
10 conditions
3 sponsors
148 locations
NCT04537286
First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients
PHASE2
Recruiting
90 participants
Started: Aug 25, 2020 · Completed: Oct 15, 2024
1 condition
1 sponsor
1 location
NCT04102371
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
PHASE3
Recruiting
8,800 participants
Started: Aug 25, 2020 · Completed: Aug 31, 2026
2 conditions
50 sponsors
24 locations
NCT04522271
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
NA
Active, not recruiting
80 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04511962
Feasibility, of Tele-rehabilitation Following COVID-19
N/A
Active, not recruiting
40 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05335603
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
N/A
Recruiting
335 participants
Started: Aug 24, 2020 · Completed: Aug 31, 2036
1 condition
2 sponsors
1 location
NCT04298255
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
NA
Recruiting
50 participants
Started: Aug 24, 2020 · Completed: Jul 31, 2026
1 condition
4 sponsors
1 location
NCT04403295
Collaborative Specialty Care for Gulf War Illness
NA
Active, not recruiting
281 participants
Started: Aug 24, 2020 · Completed: May 29, 2026
1 condition
1 sponsor
1 location
NCT04541563
Fisher Wallace Neurostimulation & Depression Study
NA
Active, not recruiting
175 participants
Started: Aug 24, 2020 · Completed: Nov 30, 2021
1 condition
2 sponsors
1 location
NCT04329429
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
PHASE2
Active, not recruiting
57 participants
Started: Aug 24, 2020 · Completed: Jun 30, 2024
1 condition
1 sponsor
16 locations
NCT04449549
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
PHASE2
Recruiting
82 participants
Started: Aug 24, 2020 · Completed: Apr 8, 2026
1 condition
1 sponsor
1 location
NCT04165564
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
N/A
Active, not recruiting
85 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2026
1 condition
3 sponsors
19 locations
NCT06125444
Impact of Hyperuricemia on Psoriatic Arthritis
N/A
Recruiting
242 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT03814356
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
PHASE1
Active, not recruiting
10 participants
Started: Aug 24, 2020 · Completed: Aug 1, 2025
4 conditions
1 sponsor
1 location
NCT04516109
Modifications of Devices for Hip Arthroscopy
NA
Enrolling by invitation
111 participants
Started: Aug 24, 2020 · Completed: Aug 31, 2026
1 condition
1 sponsor
2 locations
NCT04502602
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
PHASE1
Active, not recruiting
18 participants
Started: Aug 24, 2020 · Completed: May 31, 2029
2 conditions
3 sponsors
1 location
NCT04435288
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
PHASE3
Active, not recruiting
90 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2028
1 condition
2 sponsors
6 locations
Previous
1
More pages
2022
2023
2024
2025
2026
2027
2028
More pages
2369
Next